Stay updated with breaking news from Vp Clinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Antibody persistence of a single-doselive-attenuated chikungunya virus vaccine in adults. World Vaccine Congress, Washington 03-Apr-2024 ...
LONDON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focused on the discovery and development of a completely novel...
/PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chief executive officer Hans...
Pharmaceutical Physician, Clinical Neuroscientist, and Psychiatrist with professional experience in the pharmaceutical industry accelerates Company efforts in clinical developmentMUNICH, Germany, May 08
Saint-Herblain (France), October 10, 2022 – Valneva SE VALNVLA, a specialty vaccine company, announces today it will present on its single-shot chikungunya